PREVALENCE AND ANTIMICROBIAL SUSCEPTIBILITY OF MYCOPLASMA HOMINIS AND UREAPLASMA SPP. ISOLATED IN NATIONAL HOSPITAL OF DERMATOLOGY AND VENEREOLOGY IN 2021
Main Article Content
Abstract
Mycoplasma hominis and Ureaplasma spp., commonly found in the urogenital tract, have been associated with urogenital infections. Although only a limited number of antibiotics are available to treat these bacteria, antimicrobial resistance has been reported. Methods: This cross-sectional study aimed to investigate the prevalence and antimicrobial resistance of mycoplasmas, including Mycoplasma hominis and Ureaplasma spp., isolated in the National Hospital of Dermatology and Venereology in 2021. Results: Of the 357 genital cultures, 132 (37.0%) were positive for mycoplasmas, with 131 (36.7%) cases of Ureaplasma spp. and 38 (10.6%) cases of M. hominis. Of the 132 positive cases, 71.2% had a single infection of Ureaplasma spp. and 0.8% had a single infection of M. hominis, while 28.0% had a coinfection. The prevalence of mycoplasmas, Ureaplasma spp., and M. hominis was significantly higher in females than in males, and the highest positive rates were observed in patients aged less than 24 years. Ureaplasma spp. had a high susceptibility rate to Pristinamycin, Josamycin, and Doxycycline (98.9%, 96.8%, and 94.7%, respectively), while 78.8% and 52.1% of Ureaplasma spp. isolates were resistant to Ciprofloxacin and Ofloxacin, respectively. Conclusions: This study demonstrates a high prevalence of Ureaplasma spp. compared to M. hominis, with the prevalence of both bacteria being associated with sex and age. Pristinamycin, Josamycin, and Doxycycline show promise as effective antibiotics for the urogenital treatment of Ureaplasma spp. and M. hominis.
Article Details
Keywords
Mycoplasma hominis, Ureaplasma, resistance, prevalence.
References

2. Beeton, M.L., et al. (2016), Antibiotic Resistance among Clinical Ureaplasma Isolates Recovered from Neonates in England and Wales between 2007 and 2013. Antimicrob Agents Chemother. 60(1): p. 52-6.

3. Foschi, C., et al. (2018), Prevalence and antimicrobial resistance of genital Mollicutes in Italy over a two-year period. New Microbiol. 41(2): p. 153-158.

4. Jang, Y.S., J.W. Min, and Y.S. Kim (2019), Positive culture rate and antimicrobial susceptibilities of Mycoplasma hominis and Ureaplasma urealyticum. Obstet Gynecol Sci. 62(2): p. 127-133.

5. Kasprzykowska, U., et al. (2018), A twelve-year retrospective analysis of prevalence and antimicrobial susceptibility patterns of Ureaplasma spp. and Mycoplasma hominis in the province of Lower Silesia in Poland. Eur J Obstet Gynecol Reprod Biol. 220: p. 44-49.

6. Lee, J.Y. and J.S. Yang (2020), Prevalence and Antimicrobial Susceptibility of Mycoplasma hominis and Ureaplasma Species in Nonpregnant Female Patients in South Korea Indicate an Increasing Trend of Pristinamycin-Resistant Isolates. Antimicrob Agents Chemother. 64(10).

7. Schneider, S.C., et al. (2015), Antibiotic Susceptibility and Sequence Type Distribution of Ureaplasma Species Isolated from Genital Samples in Switzerland. Antimicrob Agents Chemother. 59(10): p. 6026-31.

8. Song, J., et al. (2022), Prevalence and antibiotics resistance of Ureaplasma species and Mycoplasma hominis in Hangzhou, China, from 2013 to 2019. Front Microbiol. 13: p. 982429.
